January 26, 2007 5:00 PM
- Text
Spray For Premature Ejaculation Helps
- Low Vitamin D in Pregnancy Linked to Language Problems in Children
- Overeating May Raise Risk for Memory Problems
- Chinese Herb Targets Immune System
- Adele's Grammy Comeback After Vocal Cord Surgery
- Treating Sleep Apnea in Kids Improves Behavior, Quality of Life
- Chemo May Not Harm Unborn Baby
- More from WebMD »
GENERIC: Men Health, Caduceus, Da Vinci, Cancer, Prostate, Urology, Man, Lung (CBS)
(WebMD)
An anesthetic spray more than doubles the "lasting" time for men with premature ejaculation, according to a study by the company that makes the experimental spray.
The metered-dose, aerosol spray is a mixture of the anesthetics lidocaine and prilocaine. It is spritzed onto the tip of the penis 15 minutes before sex.
Before using the spray, the 54 heterosexual men in the study ejaculated, on average, one minute after vaginal penetration.
In the test, on four occasions, half the men used the anesthetic spray 15 minutes before sex, the other half a placebo with no active ingredients.
The men or their partners used a stopwatch to measure the time from vaginal penetration to ejaculation.
The results:
Premature ejaculation isn't defined by a specific time until ejaculation. According to the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV), premature ejaculation is "persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the person wishes it."
About 70 percent of men who used the spray and just under 50 percent of the men who used the placebo said they had longer time to ejaculation.
About 60 percent of the female partners of men who used the spray, and about 30 percent of the partners of the men who used the placebo, said the men had better control over their ejaculation.
The spray is called TEMPE — topical eutectic mixture for premature ejaculation — by manufacturer Plethora Solutions Ltd. London, which funded the study. It is not yet available on the market.
"TEMPE 'as required' has the potential to offer a convenient, novel treatment option for men with premature ejaculation," conclude researchers Wallace C. Dinsmore, M.D., of Royal Victoria Hospital, Belfast, Northern Ireland, and colleagues.
The spray had few side effects.
Four of the 26 men who used TEMPE did report side effects. Three had numbness of the penis, and one reported erectile dysfunction.
Only one of the men's sex partners reported a side effect: a mild burning sensation during intercourse.
Emla, from AstraZeneca, is also a mixture of lidocaine and prilocaine. It comes in a cream formulation and must be used with a condom. TEMPE does not require condom use.
The study appears in the February issue of the urology journal BJU International.
By Daniel DeNoon
Reviewed by Louise Chang
The metered-dose, aerosol spray is a mixture of the anesthetics lidocaine and prilocaine. It is spritzed onto the tip of the penis 15 minutes before sex.
Before using the spray, the 54 heterosexual men in the study ejaculated, on average, one minute after vaginal penetration.
In the test, on four occasions, half the men used the anesthetic spray 15 minutes before sex, the other half a placebo with no active ingredients.
The men or their partners used a stopwatch to measure the time from vaginal penetration to ejaculation.
The results:
- Lasting time increased to two minutes or more for 55 percent of the men who got the spray and 35 percent of the men who got the placebo.
- Lasting time increased to three minutes or more for 40 percent of the men who got the spray and 13 percent of the men who got the placebo.
- Lasting time increased to four minutes or more for 20 percent of the men who got the spray and 13 percent of the men who got the placebo.
- On average, men who got the spray lasted 2.4 times longer than those who got the placebo.
Premature ejaculation isn't defined by a specific time until ejaculation. According to the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV), premature ejaculation is "persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the person wishes it."
About 70 percent of men who used the spray and just under 50 percent of the men who used the placebo said they had longer time to ejaculation.
About 60 percent of the female partners of men who used the spray, and about 30 percent of the partners of the men who used the placebo, said the men had better control over their ejaculation.
The spray is called TEMPE — topical eutectic mixture for premature ejaculation — by manufacturer Plethora Solutions Ltd. London, which funded the study. It is not yet available on the market.
"TEMPE 'as required' has the potential to offer a convenient, novel treatment option for men with premature ejaculation," conclude researchers Wallace C. Dinsmore, M.D., of Royal Victoria Hospital, Belfast, Northern Ireland, and colleagues.
The spray had few side effects.
Four of the 26 men who used TEMPE did report side effects. Three had numbness of the penis, and one reported erectile dysfunction.
Only one of the men's sex partners reported a side effect: a mild burning sensation during intercourse.
Emla, from AstraZeneca, is also a mixture of lidocaine and prilocaine. It comes in a cream formulation and must be used with a condom. TEMPE does not require condom use.
The study appears in the February issue of the urology journal BJU International.
SOURCES: Dinsmore, W., BJU International, February 2007; vol 99: pp 369-375. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.
By Daniel DeNoon
Reviewed by Louise Chang
Popular Now in Health
- 4.5 million Americans over 50 have artificial knees
- Cancer drug reverses Alzheimer's in mice: Study
- Marijuana-smoking motorists twice as likely to crash
- Skin cancer self-exam: What to look for (PHOTOS)
- Things You Didn't Know About Your Penis
- HealthPop: Online dating and jaw engraving
- PICTURES: 15 Shocking Sexual Fetishes
- Christina Hendricks: Too Big for Hollywood?
- Whitney Houston back in rehab: Why?
- John Dye Dies: What Killed "Angel" Star?
- Woman spotlights uterus didelphys on talk show
- Online dating downsides, romantic tattoo gone wrong: HealthPop Valentine's Day video
- 8 Tips For Losing Weight After Pregnancy
- Glen Campbell downplays Alzheimer's diagnosis
- Caffeine inhalers - the next club drug?
- Demi Moore's hospitalization spotlights whippets
- Jennifer Hudson: Is singer now too thin?
Latest CBS News Headlines
on Facebook Most Discussed Stories
on CBS News
- Tropical Latin theme lightens up post-Grammy party
- Syrian rebels repel government troops in key town
- The nations weather
- Red Wings match record with 20th straight home win
on Facebook Most Discussed Stories
on CBS News






